(2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide

C118H107N17O12S7 — CID 160953358

IUPAC(2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide
SMILESO=C(Nc1nc(CCCN2CCOCC2)cs1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O.O=C(Nc1ncc(CCCN2CCOCC2)s1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O.O=C(Nc1nccs1)[C@@H](c1ccccc1)N1Cc2cc(-c3cccs3)ccc2C1=O.O=C(Nc1nccs1)[C@@H](c1ccccc1)N1Cc2cc(-c3ccsc3)ccc2C1=O.O=C(Nc1nccs1)[C@H](Cc1ccccc1)N1Cc2ccccc2C1=O
InChIInChI=1S/2C26H28N4O3S.2C23H17N3O2S2.C20H17N3O2S/c31-24(28-26-27-17-21(34-26)10-6-12-29-13-15-33-16-14-29)23(19-7-2-1-3-8-19)30-18-20-9-4-5-11-22(20)25(30)32;31-24(28-26-27-21(18-34-26)10-6-12-29-13-15-33-16-14-29)23(19-7-2-1-3-8-19)30-17-20-9-4-5-11-22(20)25(30)32;27-21(25-23-24-10-12-30-23)20(15-5-2-1-3-6-15)26-14-17-13-16(19-7-4-11-29-19)8-9-18(17)22(26)28;27-21(25-23-24-9-11-30-23)20(15-4-2-1-3-5-15)26-13-18-12-16(17-8-10-29-14-17)6-7-19(18)22(26)28;24-18(22-20-21-10-11-26-20)17(12-14-6-2-1-3-7-14)23-13-15-8-4-5-9-16(15)19(23)25/h1-5,7-9,11,17,23H,6,10,12-16,18H2,(H,27,28,31);1-5,7-9,11,18,23H,6,10,12-17H2,(H,27,28,31);1-13,20H,14H2,(H,24,25,27);1-12,14,20H,13H2,(H,24,25,27);1-11,17H,12-13H2,(H,21,22,24)/t2*23-;2*20-;17-/m11110/s1
InChIKeySWBBKTKNHGNZRH-NUKVYSTBSA-N
MW2179.73 g/mol
LogP21.25
Rot. Bonds31

About (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide

(2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide (PubChem CID 160953358) has the molecular formula C118H107N17O12S7 and a molecular weight of 2179.73 g/mol. Its IUPAC name is (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide.

Molecular Properties

Compound Name(2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide
PubChem CID160953358
Molecular FormulaC118H107N17O12S7
Molecular Weight2179.73 g/mol
Exact Mass2177.63
IUPAC Name(2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide
SMILESO=C(Nc1nc(CCCN2CCOCC2)cs1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O.O=C(Nc1ncc(CCCN2CCOCC2)s1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O.O=C(Nc1nccs1)[C@@H](c1ccccc1)N1Cc2cc(-c3cccs3)ccc2C1=O.O=C(Nc1nccs1)[C@@H](c1ccccc1)N1Cc2cc(-c3ccsc3)ccc2C1=O.O=C(Nc1nccs1)[C@H](Cc1ccccc1)N1Cc2ccccc2C1=O
InChIInChI=1S/2C26H28N4O3S.2C23H17N3O2S2.C20H17N3O2S/c31-24(28-26-27-17-21(34-26)10-6-12-29-13-15-33-16-14-29)23(19-7-2-1-3-8-19)30-18-20-9-4-5-11-22(20)25(30)32;31-24(28-26-27-21(18-34-26)10-6-12-29-13-15-33-16-14-29)23(19-7-2-1-3-8-19)30-17-20-9-4-5-11-22(20)25(30)32;27-21(25-23-24-10-12-30-23)20(15-5-2-1-3-6-15)26-14-17-13-16(19-7-4-11-29-19)8-9-18(17)22(26)28;27-21(25-23-24-9-11-30-23)20(15-4-2-1-3-5-15)26-13-18-12-16(17-8-10-29-14-17)6-7-19(18)22(26)28;24-18(22-20-21-10-11-26-20)17(12-14-6-2-1-3-7-14)23-13-15-8-4-5-9-16(15)19(23)25/h1-5,7-9,11,17,23H,6,10,12-16,18H2,(H,27,28,31);1-5,7-9,11,18,23H,6,10,12-17H2,(H,27,28,31);1-13,20H,14H2,(H,24,25,27);1-12,14,20H,13H2,(H,24,25,27);1-11,17H,12-13H2,(H,21,22,24)/t2*23-;2*20-;17-/m11110/s1
InChIKeySWBBKTKNHGNZRH-NUKVYSTBSA-N
XLogP21.25
TPSA336.44 Ų
H-Bond Donors5
H-Bond Acceptors26
Rotatable Bonds31
Heavy Atoms154
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002179.73
LogP ≤ 521.25
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1026

Analyze (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide?
The IUPAC name of (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide (CID 160953358) is (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide.
What is the SMILES notation for (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide?
The canonical SMILES for (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide is O=C(Nc1nc(CCCN2CCOCC2)cs1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O.O=C(Nc1ncc(CCCN2CCOCC2)s1)[C@@H](c1ccccc1)N1Cc2ccccc2C1=O.O=C(Nc1nccs1)[C@@H](c1ccccc1)N1Cc2cc(-c3cccs3)ccc2C1=O.O=C(Nc1nccs1)[C@@H](c1ccccc1)N1Cc2cc(-c3ccsc3)ccc2C1=O.O=C(Nc1nccs1)[C@H](Cc1ccccc1)N1Cc2ccccc2C1=O.
What is the InChIKey of (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide?
The InChIKey is SWBBKTKNHGNZRH-NUKVYSTBSA-N. The full InChI is InChI=1S/2C26H28N4O3S.2C23H17N3O2S2.C20H17N3O2S/c31-24(28-26-27-17-21(34-26)10-6-12-29-13-15-33-16-14-29)23(19-7-2-1-3-8-19)30-18-20-9-4-5-11-22(20)25(30)32;31-24(28-26-27-21(18-34-26)10-6-12-29-13-15-33-16-14-29)23(19-7-2-1-3-8-19)30-17-20-9-4-5-11-22(20)25(30)32;27-21(25-23-24-10-12-30-23)20(15-5-2-1-3-6-15)26-14-17-13-16(19-7-4-11-29-19)8-9-18(17)22(26)28;27-21(25-23-24-9-11-30-23)20(15-4-2-1-3-5-15)26-13-18-12-16(17-8-10-29-14-17)6-7-19(18)22(26)28;24-18(22-20-21-10-11-26-20)17(12-14-6-2-1-3-7-14)23-13-15-8-4-5-9-16(15)19(23)25/h1-5,7-9,11,17,23H,6,10,12-16,18H2,(H,27,28,31);1-5,7-9,11,18,23H,6,10,12-17H2,(H,27,28,31);1-13,20H,14H2,(H,24,25,27);1-12,14,20H,13H2,(H,24,25,27);1-11,17H,12-13H2,(H,21,22,24)/t2*23-;2*20-;17-/m11110/s1.
What are the key properties of (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide?
(2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide has a molecular weight of 2179.73 g/mol, XLogP of 21.25, 31 rotatable bonds, 5 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[4-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2R)-N-[5-(3-morpholin-4-ylpropyl)-1,3-thiazol-2-yl]-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetamide;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-(1,3-thiazol-2-yl)propanamide;(2R)-2-(3-oxo-6-thiophen-2-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide;(2R)-2-(3-oxo-6-thiophen-3-yl-1H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide is sourced from PubChem (CID 160953358), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).